EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinicopathological Characteristics of Ovarian and Breast Cancer in PALB2, RAD51C, and RAD51D Germline Pathogenic Variant Carriers

Jella-Rike J A H Spijkervet, L Lanjouw iD, L P V Berger iD, M D Dorrius, B van der Vegt iD, G H de Bock iD

Genes · 2025

DOI: 10.3390/genes16050556 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2025. Verfasst von Jella-Rike J A H Spijkervet und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands. Hauptthemen laut MEDLINE: Fanconi Anemia Complementation Group N Protein, Breast Neoplasms, Germ-Line Mutation, Ovarian Neoplasms. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Germline pathogenic variants (GPVs) in PALB2, RAD51C, and RAD51D increase breast cancer (BC) and ovarian cancer (OC) risk. Limited data on clinicopathological characteristics of BC and OC in women with these GPVs hamper guideline development. Therefore, this study aims to describe these characteristics in a consecutive series of female PALB2, RAD51C, and RAD51D GPV carriers.

Methods

Women with a PALB2, RAD51C, or RAD51D GPV determined before July 2023 at the University Medical Center Groningen were included. Cancer diagnoses were obtained through linkage with the Dutch Nationwide Pathology Databank (Palga). Median onset age and histopathological subtypes were compared to the data of The Netherlands Cancer Registry (NCR).

Results

Among 164 GPV carriers (125 PALB2, 30 RAD51C, and 9 RAD51D), 54 BC and 6 OC cases were identified. The median BC onset age was 52 (n = 50), 71 (n = 3), and 43 years (n = 1) for PALB2, RAD51C, and RAD51D, respectively, compared with 62 years in the NCR. No BC histological subtype differences were observed in PALB2 carriers. The populations of RAD51C and RAD51D carriers were too small to compare to NCR data. No OC cases occurred in PALB2 carriers. The median OC onset age was 66 (n = 4) and 56 years (n = 2) for RAD51C and RAD51D carriers, respectively, versus 67 years in the NCR. All RAD51D carriers had high-grade serous carcinoma, compared to 51.5% in the NCR.

Conclusions

Differences in onset age and histological subtypes were observed between GPV carriers and national data. Further research on cancer characteristics is needed to optimize counseling and cancer prevention in these women.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fanconi Anemia Complementation Group N ProteinBreast NeoplasmsGerm-Line MutationOvarian NeoplasmsDNA-Binding ProteinsHumansFemaleMiddle AgedAdultAgedHeterozygoteGenetic Predisposition to DiseaseNetherlands

Stichwörter der Autor:innen

PALB2RAD51CRAD51Dcancer screeninggenetic counselinghereditary breast and ovarian cancer syndromepractice guideline

Substanzen

Fanconi Anemia Complementation Group N ProteinPALB2 protein, humanRAD51C protein, humanDNA-Binding ProteinsRAD51D protein, human

Autor:innen und Institutionen

  • Department of Epidemiology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.
  • Department of Genetics, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.
  • Department of Radiology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.
  • Department of Pathology & Medical Biology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.

ORCID-Profile: L Lanjouw, L P V Berger, B van der Vegt, G H de Bock

Zitieren

APA

Spijkervet, J. J. A. H., Lanjouw, L., Berger, L. P. V., Dorrius, M. D., van der Vegt, B., & de Bock, G. H. (2025). Clinicopathological Characteristics of Ovarian and Breast Cancer in PALB2, RAD51C, and RAD51D Germline Pathogenic Variant Carriers. Genes. https://doi.org/10.3390/genes16050556

Vancouver

Spijkervet JJAH, Lanjouw L, Berger LPV, Dorrius MD, van der Vegt B, de Bock GH. Clinicopathological Characteristics of Ovarian and Breast Cancer in PALB2, RAD51C, and RAD51D Germline Pathogenic Variant Carriers. Genes. 2025. doi:10.3390/genes16050556

BibTeX
@article{Spijkervet2025,
  author = {Spijkervet, Jella-Rike J A H and Lanjouw, L and Berger, L P V and Dorrius, M D and van der Vegt, B and de Bock, G H},
  title = {Clinicopathological Characteristics of Ovarian and Breast Cancer in PALB2, RAD51C, and RAD51D Germline Pathogenic Variant Carriers},
  journal = {Genes},
  year = {2025},
  doi = {10.3390/genes16050556}
}
Kostenlos starten →